Hallador Energy Advances Expansion into Natural Gas Power Generation through ERAS Application TERRE HAUTE, Ind., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Hallador Energy Company (Nasdaq: HNRG) (“Hallador” or the “Company”) today announced that the Company has finalized its application into the Expedited Resource Addition Study (ERAS) program and has made deposits totaling approximately $13 million as required under the application process. The application provides an expedited pathway for up to 515 MW of natural gas generation adjacent to Hallador’s Merom Generating Station. “Finalizing our app...
Gran Tierra Energy Inc. Announces 2026 Guidance and Operations Update Targeting Free Cash Flow of $60 to $80 Million in the 2026 Base CaseEcuador Program Transition From Exploration to Appraisal & Development Colombia Program Focused on Maximizing Free Cash Flow Development Program Focused on Quick Payouts and Capital Efficient Projects2026 Capital Program Fulfills Commitments Over the Suroriente Block Reported Current Company Production of 48,000 to 49,000 BOEPD CALGARY, Alberta, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GT...
Moody's Ratings (Moody's) has placed Gran Tierra Energy Inc.'s ("Gran Tierra") Corporate Family Rating and senior secured notes B2 ratings under review for downgrade. Previously, the outlook was positive. RATINGS RATIONALE / FACTORS THAT COULD LEAD TO AN UPGRADE OR DOWNGRADE OF THE RATINGS The r...
Hallador Energy Company Reports Third Quarter 2025 Financial and Operating Results - Q3 Total Revenue up 40% YoY to $146.8 Million -- Q3 Net Income Increases to $23.9 Million or $0.56 Earnings per Share -- Q3 Operating Cash Flow of $23.2 Million -- Q3 Adjusted EBITDA up 1.6x to $24.9 Million -- Filed ERAS Application for 525MW Gas Generation Expansion - TERRE HAUTE, Ind., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Hallador Energy Company (Nasdaq: HNRG) (“Hallador” or the “Company”) today reported its financial results for the third quarter ended September 30, 2025. “This was an exceptional qua...
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development - Rapidly advancing NXT-41x to address significant unmet medical need for plastic and reconstructive surgery, which represents an estimated $1.5 billion U.S. market opportunity Conference call today at 5:00 p.m. ET / 2:00 p.m. PT GAITHERSBURG, Md., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a business update and financ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.